Press release
Leading Growth Driver in the Post-Traumatic Stress Disorder Therapeutics Market in 2025: Surge In PTSD Cases Drives Growth In Therapeutics Market Driver's Influence
The global increase in cases of post-traumatic stress disorder (PTSD) is anticipated to stimulate the expansion of the market for PTSD therapeutics. PTSD is a condition that emerges in individuals who have endured terrifying, surprising or threatening events. Treatments for PTSD, such as psychotherapy and medication, can assist individuals in regaining control over their lives. For example, the UK's Ministry of Defence (MoD) Department of Community Mental Health (DCMH), a company which provides mental health services to current service members and reservists, reported in March 2024 that the number of military personnel undergoing initial PTSD evaluations by mental health specialists escalated from 266 cases in 2022 to 320 cases in 2023, as stated on a UK-based defense industry news website. This significant increase in recorded PTSD cases is subsequently fueling the growth of the post-traumatic stress disorder therapeutics market.
https://www.thebusinessresearchcompany.com/report/post-traumatic-stress-disorder-therapeutics-global-market-report
How will the growth rate of the post-traumatic stress disorder therapeutics market shape industry trends by 2034?
In recent years, there has been consistent growth in the market size of therapeutics for post-traumatic stress disorder (PTSD). This market is predicted to expand from $1.14 billion in 2024 to $1.19 billion in 2025, experiencing a compound annual growth rate (CAGR) of 4.9%. Several factors from the historic period have contributed to this growth, including increased awareness about PTSD, a rise in trauma incidence rates, various government campaigns, progress in diagnostic methods, the diminishing stigma related to mental health, the introduction of psychological support programs, and a concentrated focus on veterans' healthcare.
In the coming years, the market size for therapeutics for post-traumatic stress disorder is anticipated to undergo steady expansion. The predicted growth has it reaching $1.38 billion by 2029, with a compound annual growth rate (CAGR) of 3.8%. Factors contributing to the growth expected during this forecast period include enhanced availability of mental health services, mental health policies implemented by the government, research in biology and neurology, instances of PTSD in civilian populations, and strategies for crisis response. Key trends projected during this forecast period encompass the incorporation of digital therapeutics, strides in pharmacological treatment approaches, the use of neurostimulation and brain stimulation techniques, therapy aided by psychedelics, and joint research efforts.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9214&type=smp
What trends are poised to drive the future success of the post-traumatic stress disorder therapeutics market?
Important collaborations, financial support, and investments have surfaced as a significant pattern in the post-traumatic stress disorder therapeutics industry. Predominant firms in the marketplace have been cultivating strategic collaborations and investments to fortify their market position. For example, Professor Dan Lubman AM, Dr. Shalini Arunogiri, and Dr. Paul Liknaitzky from Monash University - part of an interdisciplinary research group - were granted over $1.9 million in January 2022. Their research focuses on the effectiveness of MDMA-assisted psychological intervention for the treatment of alcohol use disorder (AUD) and post-traumatic stress disorder (PTSD). This exploration is one of seven clinical trials initiated by the Medical Research Future Fund (MRFF) under the auspices of the Federal government this month, aiming to examine the potential of innovative combination drugs to address severe mental illnesses.
Which primary segments of the post-traumatic stress disorder therapeutics market are driving growth and industry transformations?
The post-traumatic stress disorder therapeutics market covered in this report is segmented -
1) By Drug Class: Antidepressants, Anti-Anxiety, Antihypertensive, Monoamine Oxidase (MAOs), Antipsychotics Or Second Generation Antipsychotics (SGOs), Beta-Blockers, Other Classes
2) By Age Group: Pediatric, Geriatric, Adult
3) By End User: Mental Health Center, Hospitals, Outpatient Clinics, Other End Users
Subsegments:
1) By Antidepressants: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
2) By Anti-Anxiety: Benzodiazepines, Buspirone
3) By Antihypertensive: Prazosin, Clonidine
4) By Monoamine Oxidase Inhibitors (MAOs): Traditional MAOIs, Reversible MAOIs
5) By Antipsychotics (Second Generation Antipsychotics - SGOs): Risperidone, Quetiapine
6) By Beta-Blockers: Propranolol, Atenolol
7) By Other Classes: Mood Stabilizers, Adjunctive Therapies
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9214
Which geographical regions are pioneering growth in the post-traumatic stress disorder therapeutics market?
North America was the largest region in the post-traumatic stress disorder therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-traumatic stress disorder therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the influential players reshaping the post-traumatic stress disorder therapeutics market landscape?
Major companies operating in the post-traumatic stress disorder therapeutics market include Pfizer Inc., GlaxoSmithKline plc, Bionomics Limited, Otsuka Pharmaceutical Co Ltd., Eli Lilly and Company, AstraZeneca plc, Tonix Pharmaceuticals Holding Corp., Freespira Inc., MicroTransponder Inc., Compass Pathways plc, Boehringer Ingelheim International GmbH, Halucenex Life Sciences Inc., Bionorica SE, MAPS Europe BV, Hoffmann-La Roche Ltd., Praxis Precision Medicines Inc., H Lundbeck A/S, Johnson & Johnson, Sanofi SA, Takeda Pharmaceutical Company Limited, Merck KGaA, Jazz Pharmaceuticals plc
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9214&type=smp
What Is Covered In The Post-Traumatic Stress Disorder Therapeutics Global Market Report?
• Market Size Forecast: Examine the post-traumatic stress disorder therapeutics market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the post-traumatic stress disorder therapeutics market for a structured understanding.
• Key Players Overview: Analyze major players in the post-traumatic stress disorder therapeutics market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the post-traumatic stress disorder therapeutics market.
• Segment Contributions: Evaluate how different segments drive overall growth in the post-traumatic stress disorder therapeutics market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the post-traumatic stress disorder therapeutics market.
• Industry Challenges: Identify potential risks and obstacles affecting the post-traumatic stress disorder therapeutics market.
• Competitive Landscape: Review strategic developments in the post-traumatic stress disorder therapeutics market, including expansions, agreements, and new product launches.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.
Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Growth Driver in the Post-Traumatic Stress Disorder Therapeutics Market in 2025: Surge In PTSD Cases Drives Growth In Therapeutics Market Driver's Influence here
News-ID: 3893066 • Views: …
More Releases from The Business Research Company
Global High-Resolution Anoscopy Market Outlook 2025-2034: Trends, Innovations, A …
The High-Resolution Anoscopy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the High-Resolution Anoscopy Market Size and Projected Growth Rate?
The market size for high-resolution anoscopy has experienced significant growth over the past few years. The market is predicted to increase from $15.03 billion…
Condyloma Acuminata Treatment Market Size Projected To Reach $2.2 Billion By 203 …
"The Condyloma Acuminata Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Condyloma Acuminata Treatment Market Size During the Forecast Period?
In the past few years, the condyloma acuminata treatment market has seen significant growth. The market value, which is anticipated to…
Household Type Fans Market Forecast 2025-2034: Comprehensive Analysis And Growth …
"The Household Type Fans Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Household Type Fans Market?
The market size for household fans has seen consistent expansion in recent years. The projections indicate an increase from $32.22 billion in 2024…
Grain Fumigants Industry Report 2025-2034: Market Dynamics, Trends, And Forecast …
The Grain Fumigants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Grain Fumigants Market Size During the Forecast Period?
The Grain Fumigants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This…
More Releases for PTSD
Burch Tree Counseling Center Now Offering EMDR Therapy for PTSD and Trauma
Burch Tree Counseling Center is proud to announce the addition of Eye Movement Desensitization and Reprocessing (EMDR) therapy to its services, providing a powerful tool for individuals struggling with Post-Traumatic Stress Disorder (PTSD) and trauma.
As an evidence-based treatment recognized by organizations such as the American Psychological Association (APA) and the Department of Veterans Affairs (VA), EMDR therapy is designed to help clients process and heal from distressing memories. Unlike traditional…
Post Traumatic Stress Disorder (PTSD) Market Report and Forecast 2024-2032
The post-traumatic stress disorder (PTSD) market size  is expected to grow at a CAGR of 5.4 % during the forecast period of 2024-2032 in the major markets, driven by increasing prevalence of post-traumatic stress disorder (PTSD), along with reducing stigma around mental health conditions.
Post Traumatic Stress Disorder (PTSD):Â
Post Traumatic Stress Disorder (PTSD) is a mental health condition triggered by experiencing or witnessing a terrifying event. Symptoms include flashbacks, nightmares, severe…
Post Traumatic Stress Disorder (PTSD) Therapeutics Market Value Expected to Expa …
Post Traumatic Stress Disorder (PTSD) Therapeutics Market is expected to witness moderate growth registering 4.4% CAGR during the forecast period (2023-2029).
By observing alternative approaches, this Post Traumatic Stress Disorder (PTSD) Treatment Market research report aims to analyze the sales force for distribution of goods. It helps key players reduce investment risk by providing relevant data and business considerations. Key organizations can easily get a clear view of current market…
PTSD-suffering Army Medic’s Assistance Dog Campaign backed by Gloucestershireâ …
Summary: Gloucestershire dog training and rehoming centre CK9 School is supporting ex-army medic and PTSD sufferer Richard Mearns’ assistance dog campaign.
Body: CK9 School is hot on the heels of the assistance dog campaign launched by former Army medic Richard Mearns, and has called for increased awareness of these working dogs and more support for soldiers with PTSD.
Mr Mearns was diagnosed with Post Traumatic Stress Disorder in 2009. He was…
PTSD Exhibits Emerging Pipeline with 23 Drug Candidates
The study analysed that the PTSD pipeline comprises of 23 drug candidates, of which one drug candidate is in the Phase III stage of development, two drug candidates are in the Phase II stage of development, seven drug candidates are in the Pre-Clinical stage of development, two drug candidates are in Discovery stage, one drug candidate is in Unknown Clinical stage, one drug candidate is in the Discontinued stage and…
Donald Trump And PTSD: PTSD Is Not A Sign Of Weakness Says June Sitler, Author O …
PTSD can take many forms. When one hears Post Traumatic Stress Disorder (PTSD) the image of a Vietnam Vet comes to mind. However, many people from all walks of life may suffer from this disorder. They are the survivors. They can be people who live in the inner city, those who have suffered the loss of a loved one, survivors of childhood trauma in adulthood, or a man or woman…
